|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-10-19
|
|
pubmed:abstractText |
The currently used National Cancer Institute (NCI) adverse events criteria for mucosal barrier injury (MBI) are insufficient for use in children. We searched for objective, easily measurable indicators for MBI in children with cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amsacrine,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Carbohydrates,
http://linkedlifedata.com/resource/pubmed/chemical/Citrulline,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-8,
http://linkedlifedata.com/resource/pubmed/chemical/Leukocyte L1 Antigen Complex,
http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2009 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1188-94
|
|
pubmed:meshHeading |
pubmed-meshheading:19688831-Acute Disease,
pubmed-meshheading:19688831-Adolescent,
pubmed-meshheading:19688831-Amsacrine,
pubmed-meshheading:19688831-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19688831-Biological Markers,
pubmed-meshheading:19688831-Carbohydrates,
pubmed-meshheading:19688831-Cell Death,
pubmed-meshheading:19688831-Child,
pubmed-meshheading:19688831-Child, Preschool,
pubmed-meshheading:19688831-Citrulline,
pubmed-meshheading:19688831-Cytarabine,
pubmed-meshheading:19688831-DNA,
pubmed-meshheading:19688831-Daunorubicin,
pubmed-meshheading:19688831-Enterocytes,
pubmed-meshheading:19688831-Etoposide,
pubmed-meshheading:19688831-Feces,
pubmed-meshheading:19688831-Female,
pubmed-meshheading:19688831-Humans,
pubmed-meshheading:19688831-Infant,
pubmed-meshheading:19688831-Interleukin-8,
pubmed-meshheading:19688831-Intestinal Absorption,
pubmed-meshheading:19688831-Leukemia, Myeloid,
pubmed-meshheading:19688831-Leukocyte L1 Antigen Complex,
pubmed-meshheading:19688831-Male,
pubmed-meshheading:19688831-Mitoxantrone,
pubmed-meshheading:19688831-Models, Biological,
pubmed-meshheading:19688831-Mucositis,
pubmed-meshheading:19688831-Stomatitis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.
|
|
pubmed:affiliation |
Division of Pediatric Oncology/Hematology, Beatrix Children's Hospital, University of Groningen, Groningen, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
